An open study of human lymphoblastoid interferon and oral acyclovir in chronic hepatitis B virus infection
β Scribed by Guarascio, Paolo; De Felici, Anna Paola; Migliorini, Daniela; Alexander, Graeme J.M.; Fagan, Elizabeth A.; Visco, Giuseppe
- Book ID
- 122395097
- Publisher
- Elsevier Science
- Year
- 1986
- Tongue
- English
- Weight
- 297 KB
- Volume
- 3
- Category
- Article
- ISSN
- 0168-8278
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
A randomised, controlled trial comparing acyclovir, 45 mg/kg/day as a continuous IV infusion for 28 days, with no other therapy, was carried out in 30 stable HBsAg carriers seropositive for HBeAg for more than 6 months. Twenty-eight had hepatitis B virus DNA-polymerase activity and/or hepatitis B vi
MxA protein is interferon inducible, and its role as an antiviral mediator is being studied in various viral diseases. Several cytokines, including type I interferons (β£ and β€), interleukins 2 and 12, and granulocyte, macrophage, and granulocyte-macrophage colony-stimulating factors, were tested for